Author:
Wang Suqing,Wang Meizi,Cui Jingjing,Lian Di,Li Li
Publisher
Springer Science and Business Media LLC
Subject
Law,Clinical Biochemistry,Spectroscopy,Sociology and Political Science,Social Sciences (miscellaneous),Clinical Psychology,Biochemistry
Reference40 articles.
1. Mara Livezey LD, Nagy LE, Diffenderfer, Evan J, Arthur DJ, Hsi JM (2012) Holton,and Laura Lowe Furge, Molecular Analysis and modeling of inactivation of human CYP2D6 by four mechanism based inactivators. Drug Metab Lett 6:7–14
2. Rendic S, Guengerich FP (2010) Update information on drug Metabolism Systems-2009, part II. Summary of information on the Effects of Diseases and Environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab 11:4–84
3. Lee JY, Lee SY, Oh SJ, Lee KH, Jung YS, Kim SK (2012) Assessment of drug-drug interactions caused by metabolism-dependent cytochrome P450 inhibition.Chem.-Biol. Interact.198 (1 – 3), 49 – 56.
4. Kashihara Y, Ieiri I, Yoshikado T, Kazuya M, Fukae M, Kimura M, Hirota T, Matsuki S, Irie S, Izumi N (2017) Small-dosing clinical study: pharmacokinetic, pharmacogenomic (SLCO2B1 and ABCG2), and Interaction (Atorvastatin and Grapefruit Juice) profiles of five probes for OATP2B1 and BCRP. J Pharm Sci 106:2688–2694
5. Wang RW, Newton DJ, Liu N, Atkins WM, Lu AYH (2000) Human cytochrome P450 3A4: in vitro drug–drug interaction patterns are substrate dependent. Drug Metabol Dispos 28(3):360–366